Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals

Neuroscience Letters

Volumn 483, Issue 3, 2010, Pages 201-205

  Akazawa, Yoko Ogawa ^a   Saito, Yoshiro ^a,b   Hamakubo, Takao ^c   Masuo, Yoshinori ^a   Yoshida, Yasukazu ^a   Nishio, Keiko ^a   Shichiri, Mototada ^a   Miyasaka, Tomohiro ^b   Iwanari, Hiroko ^c   Mochizuki, Yasuhiro ^c   Kodama, Tatsuhiko ^c   Noguchi, Noriko ^b   Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antibody; Biomarker; DJ 1; Enzyme linked immunosorbent assay; Erythrocytes; Oxidative stress; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DJ 1 PROTEIN; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CORPUS STRIATUM; ERYTHROCYTE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OXIDATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; MICE; ONCOGENE PROTEINS; OXIDOPAMINE; PARKINSON DISEASE; RATS; TIME FACTORS;

EID: 77956283357     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.08.007     Document Type: Article

References (21)

1. Blackinton J., Lakshminarasimhan M., Thomas K.J., Ahmad R., Greggio E., Raza A.S., Cookson M.R., Wilson M.A. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J. Biol. Chem. 2009, 284:6476-6485.
2. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
3. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
4. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.S., Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 2006, 281:10816-10824.
5. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
6. Inden M., Taira T., Kitamura Y., Yanagida T., Tsuchiya D., Takata K., Yanagisawa D., Nishimura K., Taniguchi T., Kiso Y., Yoshimoto K., Agatsuma T., Koide-Yoshida S., Iguchi-Ariga S.M., Shimohama S., Ariga H. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol. Dis. 2006, 24:144-158.
7. Kinumi T., Kimata J., Taira T., Ariga H., Niki E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2004, 317:722-728.
8. Mandel S.A., Amit T., Weinreb O., Reznichenko L., Youdim M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Therapeut. 2008, 14:352-365.
9. Mandel S., Grunblatt E., Riederer P., Gerlach M., Levites Y., Youdim M.B. Neuroprotective strategies in Parkinson's disease: an update on progress. CNS Drugs 2003, 17:729-762.
10. Manning-Bog A.B., Caudle W.M., Perez X.A., Reaney S.H., Paletzki R., Isla M.Z., Chou V.P., McCormack A.L., Miller G.W., Langston J.W., Gerfen C.R., Dimonte D.A. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol. Dis. 2007, 27:141-150.
11. Masuo Y., Ishido M., Morita M., Oka S. Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats. Neurosci. Lett. 2002, 335:124-128.
12. Masuo Y., Ishido M., Morita M., Oka S. Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats. Neural Plast. 2004, 11:59-76.
13. Paterna J.C., Leng A., Weber E., Feldon J., Bueler H. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol. Ther. 2007, 15:698-704.
14. Przedborski S., Vila M. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci. 2003, 991:189-198.
15. Saito Y., Hamakubo T., Yoshida Y., Ogawa Y., Hara Y., Fujimura H., Imai Y., Iwanari H., Mochizuki Y., Shichiri M., Nishio K., Kinumi T., Noguchi N., Kodama T., Niki E. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Neurosci. Lett. 2009, 465:1-5.
16. Saito Y., Nishio K., Ogawa Y., Kinumi T., Yoshida Y., Masuo Y., Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Rad. Biol. Med. 2007, 42:675-685.
17. Schulz J.B. Update on the pathogenesis of Parkinson's disease. J. Neurol. 2008, 255:3-7.
18. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K., Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004, 5:213-218.
19. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 2001, 276:37556-37563.
20. Tsuboi Y., Munemoto H., Ishikawa S., Matsumoto K., Iguchi-Ariga S.M., Ariga H. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. FEBS Lett. 2008, 582:2643-2649.
21. Waragai M, Wei J., Fujita M., Nakai M., Ho G.J., Masliah E., Akatsu H., Yamada T., Hashimoto M. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem. Biophys. Res. Commun. 2006, 345:967-972.